Recurrent tumors showed a pathogenic SMARCB1 copy number loss on repeat sequencing more consistent with ATRT (not present on the initial diagnostic tumor specimen) while retaining the molecular features of the original tumor (Table 1). This evidence concerns the gene SMARCB1 and neoplasm.